Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections.
Kidd, Sarah L
Osberger, Thomas J
Sore, Hannah F
Spring, David R
Frontiers Media SA
MetadataShow full item record
Kidd, S. L., Osberger, T. J., Mateu, N., Sore, H. F., & Spring, D. R. (2018). Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections.. Front Chem, 6 460. https://doi.org/10.3389/fchem.2018.00460
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medicines, illustrated by the approval of two FBBD-derived drugs. This methodology is based on the utilization of small "fragment" molecules (<300 Da) as starting points for drug discovery and optimization. Organic synthesis has been identified as a significant obstacle in FBDD, however, in particular owing to the lack of novel 3-dimensional (3D) fragment collections that feature useful synthetic vectors for modification of hit compounds. Diversity-oriented synthesis (DOS) is a synthetic strategy that aims to efficiently produce compound collections with high levels of structural diversity and three-dimensionality and is therefore well-suited for the construction of novel fragment collections. This Mini-Review highlights recent studies at the intersection of DOS and FBDD aiming to produce novel libraries of diverse, polycyclic, fragment-like compounds, and their application in fragment-based screening projects.
Our research is supported by the EPSRC, BBSRC, MRC, Wellcome Trust, and ERC (FP7/2007-2013; 279337/DOS). S.L.K. thanks AstraZeneca for funding.
Engineering and Physical Sciences Research Council (EP/J016012/1)
Royal Society (WM150022)
Engineering and Physical Sciences Research Council (EP/P020291/1)
External DOI: https://doi.org/10.3389/fchem.2018.00460
This record's URL: https://www.repository.cam.ac.uk/handle/1810/285926
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/